These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3122700)

  • 21. Evaluation of bupropion hydrochloride: the first of a new class of atypical antidepressants.
    Preskorn SH; Othmer SC
    Pharmacotherapy; 1984; 4(1):20-34. PubMed ID: 6422449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs.
    Cryan JF; Dalvi A; Jin SH; Hirsch BR; Lucki I; Thomas SA
    J Pharmacol Exp Ther; 2001 Aug; 298(2):651-7. PubMed ID: 11454927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis.
    Schildkraut JJ; Mooney JJ
    Am J Psychiatry; 2004 May; 161(5):909-11. PubMed ID: 15121658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics.
    Veith RC; Lewis N; Linares OA; Barnes RF; Raskind MA; Villacres EC; Murburg MM; Ashleigh EA; Castillo S; Peskind ER
    Arch Gen Psychiatry; 1994 May; 51(5):411-22. PubMed ID: 8179465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of the effects of desipramine treatment alone and in combination with L-triiodothyronine on 6-sulphatoxymelatonin excretion in depressed patients.
    Bearn J; Franey C; Arendt J; Checkley SA
    Br J Psychiatry; 1989 Sep; 155():341-7. PubMed ID: 2611544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice.
    Stasiuk W; Szopa A; Serefko A; Wyska E; Świąder K; Dudka J; Wlaź P; Poleszak E
    J Neural Transm (Vienna); 2017 Mar; 124(3):387-396. PubMed ID: 27900470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nocturnal urinary excretion of 6-hydroxymelatonin sulfate in prepubertal major depressive disorder.
    Waterman GS; Ryan ND; Perel JM; Dahl RE; Birmaher B; Williamson DE; Thomas CR; Puig-Antich J
    Biol Psychiatry; 1992 Mar; 31(6):582-90. PubMed ID: 1581437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bupropion and amitriptyline in the treatment of depressed patients.
    Chouinard G
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):121-9. PubMed ID: 6406440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of bupropion and amitriptyline on cardiac conduction in depressed patients.
    Wenger TL; Cohn JB; Bustrack J
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):174-5. PubMed ID: 6406452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of bupropion's mechanism of antidepressant activity.
    Ferris RM; Cooper BR; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):74-8. PubMed ID: 6406468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abrupt discontinuation of tricyclic antidepressant drugs: evidence for noradrenergic hyperactivity.
    Charney DS; Heninger GR; Sternberg DE; Landis H
    Br J Psychiatry; 1982 Oct; 141():377-86. PubMed ID: 6756531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrine.
    Perumal AS; Smith TM; Suckow RF; Cooper TB
    Neuropharmacology; 1986 Feb; 25(2):199-202. PubMed ID: 3084990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. History of antidepressants: successes and failures.
    Kelwala S; Stanley M; Gershon S
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):40-8. PubMed ID: 6222036
    [No Abstract]   [Full Text] [Related]  

  • 35. Animal models used in prediction of antidepressant effects in man.
    Cooper BR; Howard JL; Soroko FE
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):63-6. PubMed ID: 6406466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical profile of the novel antidepressant bupropion.
    Stern WC; Harto-Truax N; Rogers J; Miller L
    Adv Biochem Psychopharmacol; 1982; 32():21-34. PubMed ID: 6807060
    [No Abstract]   [Full Text] [Related]  

  • 37. Enduring attenuation of norepinephrine synaptic availability and augmentation of the pharmacological and behavioral effects of desipramine by repeated immobilization stress.
    Gonzáles MA; Miranda AP; Orrego H; Silva R; Forray MI
    Neuropharmacology; 2017 May; 117():249-259. PubMed ID: 28232061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of clorgyline on noradrenergic function.
    Ross RJ; Scheinin M; Lesieur P; Rudorfer MV; Hauger RL; Siever LJ; Linnoila M; Potter WZ
    Psychopharmacology (Berl); 1985; 85(2):227-30. PubMed ID: 3925487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders.
    Lambert G; Johansson M; Agren H; Friberg P
    Arch Gen Psychiatry; 2000 Aug; 57(8):787-93. PubMed ID: 10920468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression.
    Reed AL; Happe HK; Petty F; Bylund DB
    Psychopharmacology (Berl); 2008 Apr; 197(3):433-41. PubMed ID: 18180907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.